What is a stock summary page? Click here for an overview.
Business Description
Enfusion Inc
NAICS : 541511
SIC : 7372
ISIN : US2928121043
Share Class Description:
ENFN: Class ADescription
Enfusion Inc is a software-as-a-service (SaaS) provider focused on transforming the investment management industry. The products and services that comprise its solution are designed to eliminate technology and information barriers, empowering investment managers to confidently make and execute better-informed investment decisions in real time. It simplifies investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset resulting in a single source of truth. It generates maximum revenue from the Americas, followed by Asia Pacific and Europe, the Middle East, and Africa.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.68 | |||||
| Equity-to-Asset | 0.51 | |||||
| Debt-to-Equity | 0.28 | |||||
| Debt-to-EBITDA | 1.13 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 14.92 | |||||
| Beneish M-Score | -3.29 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5 | |||||
| 3-Year Book Growth Rate | -2.8 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 121.85 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 15.77 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 43.65 | |||||
| 9-Day RSI | 44.9 | |||||
| 14-Day RSI | 47.45 | |||||
| 3-1 Month Momentum % | 11.46 | |||||
| 6-1 Month Momentum % | 26.43 | |||||
| 12-1 Month Momentum % | 24.24 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.42 | |||||
| Quick Ratio | 3.42 | |||||
| Cash Ratio | 1.99 | |||||
| Days Sales Outstanding | 56.79 | |||||
| Days Payable | 9.49 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -13 | |||||
| Shareholder Yield % | -0.39 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 67.82 | |||||
| Operating Margin % | 3.05 | |||||
| Net Margin % | 1.4 | |||||
| FCF Margin % | 11.8 | |||||
| ROE % | 4.42 | |||||
| ROA % | 2.28 | |||||
| ROIC % | 4.27 | |||||
| 3-Year ROIIC % | 625.6 | |||||
| ROC (Joel Greenblatt) % | 10.71 | |||||
| ROCE % | 6.01 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 371.33 | |||||
| Forward PE Ratio | 39.81 | |||||
| PE Ratio without NRI | 92.83 | |||||
| PS Ratio | 6.49 | |||||
| PB Ratio | 14.47 | |||||
| Price-to-Tangible-Book | 14.47 | |||||
| Price-to-Free-Cash-Flow | 61.91 | |||||
| Price-to-Operating-Cash-Flow | 40.83 | |||||
| EV-to-EBIT | 169.85 | |||||
| EV-to-Forward-EBIT | 25.28 | |||||
| EV-to-EBITDA | 58.37 | |||||
| EV-to-Forward-EBITDA | 19.94 | |||||
| EV-to-Revenue | 5.19 | |||||
| EV-to-Forward-Revenue | 4.25 | |||||
| EV-to-FCF | 43.94 | |||||
| Price-to-GF-Value | 1.01 | |||||
| Price-to-Graham-Number | 7.68 | |||||
| Price-to-Net-Current-Asset-Value | 44.56 | |||||
| Earnings Yield (Greenblatt) % | 0.59 | |||||
| FCF Yield % | 2.25 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:ENFN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Enfusion Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 201.611 | ||
| EPS (TTM) ($) | 0.03 | ||
| Beta | 0.82 | ||
| 3-Year Sharpe Ratio | -0.07 | ||
| 3-Year Sortino Ratio | -0.1 | ||
| Volatility % | 29.76 | ||
| 14-Day RSI | 47.45 | ||
| 14-Day ATR ($) | 0.12358 | ||
| 20-Day SMA ($) | 11.144 | ||
| 12-1 Month Momentum % | 24.24 | ||
| 52-Week Range ($) | 7.83 - 11.8 | ||
| Shares Outstanding (Mil) | 94.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Enfusion Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Enfusion Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Enfusion Inc Frequently Asked Questions
What is Enfusion Inc(ENFN)'s stock price today?
The current price of ENFN is $11.14. The 52 week high of ENFN is $11.80 and 52 week low is $7.83.
When is next earnings date of Enfusion Inc(ENFN)?
The next earnings date of Enfusion Inc(ENFN) is 2025-05-09 Est..
Does Enfusion Inc(ENFN) pay dividends? If so, how much?
Enfusion Inc(ENFN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers